• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺氧诱导因子作为癌症治疗策略的另一种来源。

Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer.

机构信息

Department of Biochemistry, University of Ilorin, Ilorin, Nigeria.

Department of Biochemistry, Medicinal Biochemistry, Nanomedicine & Toxicology Laboratory, Landmark University, Omu-Aran 251101, Nigeria.

出版信息

Oxid Med Cell Longev. 2019 Aug 14;2019:8547846. doi: 10.1155/2019/8547846. eCollection 2019.

DOI:10.1155/2019/8547846
PMID:31485300
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6710762/
Abstract

Hypoxia-inducible factors (HIFs) are transcription factors that activate the transcription of genes necessary to circumvent to hypoxic (low oxygen level) environments. In carcinogenesis, HIFs play a critical role. Indeed, HIF-1 has been validated as a promising target for novel cancer therapeutics, even as clinical investigations have linked increased levels of HIF-1 with aggressive cancer progression as well as poor patient prognosis. More so, inhibiting HIF-1 activity restricted cancer progression. Therefore, HIF-1 is a viable target for cancer therapy. This may be expected considering the fact that cancer cells are known to be hypoxic. In order to survive the hypoxic microenvironment, cancer cells activate several biochemical pathways via the HIF-1. Additionally, cellular and molecular insights have proved prospects of the HIF-1 pathway for the development of novel anticancer treatment strategies. The biochemical importance of hypoxia-inducible factors (HIFs) cannot be overemphasized as carcinogenesis, cancer progression, and HIFs are intricately linked. Therefore, this review highlights the significance of these linkages and also the prospects of HIFs as an alternative source of cancer therapies.

摘要

缺氧诱导因子 (HIFs) 是转录因子,可激活适应低氧(低氧水平)环境所需基因的转录。在致癌作用中,HIFs 起着关键作用。事实上,HIF-1 已被验证为新型癌症治疗的有前途的靶点,即使临床研究已经将 HIF-1 水平的升高与侵袭性癌症进展以及患者预后不良联系起来。更重要的是,抑制 HIF-1 活性限制了癌症的进展。因此,HIF-1 是癌症治疗的可行靶点。考虑到癌细胞通常处于缺氧状态,这可能是意料之中的。为了在低氧微环境中存活,癌细胞通过 HIF-1 激活了几种生化途径。此外,细胞和分子研究已经证明了 HIF-1 途径在开发新型抗癌治疗策略方面的前景。缺氧诱导因子 (HIFs) 的生化重要性怎么强调都不为过,因为致癌作用、癌症进展和 HIFs 是紧密相关的。因此,本综述强调了这些联系的重要性,以及 HIFs 作为癌症治疗替代来源的前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf9/6710762/68b1291a6073/OMCL2019-8547846.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf9/6710762/bccce66343df/OMCL2019-8547846.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf9/6710762/042ac1795b66/OMCL2019-8547846.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf9/6710762/68b1291a6073/OMCL2019-8547846.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf9/6710762/bccce66343df/OMCL2019-8547846.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf9/6710762/042ac1795b66/OMCL2019-8547846.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6cf9/6710762/68b1291a6073/OMCL2019-8547846.003.jpg

相似文献

1
Hypoxia-Inducible Factors as an Alternative Source of Treatment Strategy for Cancer.缺氧诱导因子作为癌症治疗策略的另一种来源。
Oxid Med Cell Longev. 2019 Aug 14;2019:8547846. doi: 10.1155/2019/8547846. eCollection 2019.
2
Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.缺氧介导的耐药性:HIFs 和细胞死亡途径功能相互作用的新见解。
Drug Resist Updat. 2011 Jun;14(3):191-201. doi: 10.1016/j.drup.2011.03.001. Epub 2011 Apr 3.
3
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.靶向缺氧诱导因子1和2的抑制剂用于癌症治疗的研究进展
Yonsei Med J. 2017 May;58(3):489-496. doi: 10.3349/ymj.2017.58.3.489.
4
Herbal nutraceuticals: safe and potent therapeutics to battle tumor hypoxia.草药类营养保健品:抗击肿瘤缺氧的安全有效治疗手段。
J Cancer Res Clin Oncol. 2020 Jan;146(1):1-18. doi: 10.1007/s00432-019-03068-x. Epub 2019 Nov 13.
5
Hypoxia, oxidative stress, and the interplay of HIFs and NRF2 signaling in cancer.缺氧、氧化应激以及 HIFs 和 NRF2 信号通路在癌症中的相互作用。
Exp Mol Med. 2024 Mar;56(3):501-514. doi: 10.1038/s12276-024-01180-8. Epub 2024 Mar 1.
6
Ibuprofen-mediated reduction of hypoxia-inducible factors HIF-1alpha and HIF-2alpha in prostate cancer cells.布洛芬介导的前列腺癌细胞中缺氧诱导因子HIF-1α和HIF-2α的减少。
Clin Cancer Res. 2003 Aug 1;9(8):3150-7.
7
Current insights and future perspectives of hypoxia-inducible factor-targeted therapy in cancer.癌症中缺氧诱导因子靶向治疗的当前见解与未来展望
J Basic Clin Physiol Pharmacol. 2018 Dec 19;30(1):11-18. doi: 10.1515/jbcpp-2017-0167.
8
Does endogenous fatty acid metabolism allow cancer cells to sense hypoxia and mediate hypoxic vasodilatation? Characterization of a novel molecular connection between fatty acid synthase (FAS) and hypoxia-inducible factor-1alpha (HIF-1alpha)-related expression of vascular endothelial growth factor (VEGF) in cancer cells overexpressing her-2/neu oncogene.内源性脂肪酸代谢是否能使癌细胞感知缺氧并介导缺氧性血管舒张?对过表达her-2/neu癌基因的癌细胞中脂肪酸合酶(FAS)与缺氧诱导因子-1α(HIF-1α)相关的血管内皮生长因子(VEGF)表达之间新型分子联系的表征。
J Cell Biochem. 2005 Apr 1;94(5):857-63. doi: 10.1002/jcb.20367.
9
Expression of hypoxia inducible factor 1α and 2α and its association with vitamin C level in thyroid lesions.缺氧诱导因子 1α 和 2α 的表达及其与甲状腺病变中维生素 C 水平的关系。
J Biomed Sci. 2017 Oct 30;24(1):83. doi: 10.1186/s12929-017-0388-y.
10
Implications of Oxygen Homeostasis for Tumor Biology and Treatment.氧稳态对肿瘤生物学及治疗的影响
Adv Exp Med Biol. 2016;903:169-85. doi: 10.1007/978-1-4899-7678-9_12.

引用本文的文献

1
Hypoxia-induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9-mediated GSK3β/β-catenin signalling.缺氧诱导的PGK1表达通过刺激MYH9介导的GSK3β/β-连环蛋白信号通路促进食管鳞状细胞癌进展。
Clin Transl Med. 2025 Jun;15(6):e70376. doi: 10.1002/ctm2.70376.
2
The Physiological Functions and Therapeutic Potential of Hypoxia-Inducible Factor-1α in Vascular Calcification.缺氧诱导因子-1α在血管钙化中的生理功能及治疗潜力
Biomolecules. 2024 Dec 12;14(12):1592. doi: 10.3390/biom14121592.
3
Systematic and comprehensive insights into HIF-1 stabilization under normoxic conditions: implications for cellular adaptation and therapeutic strategies in cancer.

本文引用的文献

1
MicroRNAs and cancer: Key paradigms in molecular therapy.微小RNA与癌症:分子治疗的关键范例
Oncol Lett. 2018 Mar;15(3):2735-2742. doi: 10.3892/ol.2017.7638. Epub 2017 Dec 19.
2
Hypoxia inducible factor (HIF) as a model for studying inhibition of protein-protein interactions.缺氧诱导因子(HIF)作为研究蛋白质-蛋白质相互作用抑制的模型。
Chem Sci. 2017 Jun 1;8(6):4188-4202. doi: 10.1039/c7sc00388a. Epub 2017 Apr 26.
3
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression.缺氧诱导因子:癌症进展的主要调节因子
对常氧条件下HIF-1稳定化的系统全面见解:对癌症细胞适应和治疗策略的启示
Cell Mol Biol Lett. 2025 Jan 6;30(1):2. doi: 10.1186/s11658-024-00682-7.
4
Progress in Precision Medicine for Head and Neck Cancer.头颈癌精准医学的进展
Cancers (Basel). 2024 Nov 4;16(21):3716. doi: 10.3390/cancers16213716.
5
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?Th17细胞在癌症中的作用:免疫抑制剂还是抗肿瘤盟友?
Cancer Cell Int. 2024 Oct 27;24(1):355. doi: 10.1186/s12935-024-03525-9.
6
A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update.从分子角度探讨 HIF-1α 和血管生成刺激因子网络及其在实体瘤中的作用:最新进展。
Int J Mol Sci. 2024 Mar 14;25(6):3313. doi: 10.3390/ijms25063313.
7
Gastric Cancer: Molecular Mechanisms, Novel Targets, and Immunotherapies: From Bench to Clinical Therapeutics.胃癌:分子机制、新靶点与免疫疗法:从实验室到临床治疗
Cancers (Basel). 2023 Oct 20;15(20):5075. doi: 10.3390/cancers15205075.
8
Spatial transcriptomic analysis of tumour with high and low CAIX expression in TNBC tissue samples using GeoMx™ RNA assay.使用 GeoMx™ RNA 检测分析 TNBC 组织样本中高表达和低表达 CAIX 的肿瘤的空间转录组学。
Histol Histopathol. 2024 Feb;39(2):177-200. doi: 10.14670/HH-18-655. Epub 2023 Jul 31.
9
Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications.探讨肿瘤微环境中内皮细胞、免疫细胞和免疫检查点之间的串扰:新的见解和治疗意义。
Cell Death Dis. 2023 Sep 4;14(9):586. doi: 10.1038/s41419-023-06119-x.
10
Discovery of novel direct small-molecule inhibitors targeting HIF-2α using structure-based virtual screening, molecular dynamics simulation, and MM-GBSA calculations.基于结构的虚拟筛选、分子动力学模拟和 MM-GBSA 计算发现新型靶向 HIF-2α 的小分子直接抑制剂。
Mol Divers. 2024 Jun;28(3):1203-1224. doi: 10.1007/s11030-023-10650-6. Epub 2023 Apr 29.
Trends Cancer. 2016 Dec;2(12):758-770. doi: 10.1016/j.trecan.2016.10.016. Epub 2016 Nov 16.
4
HIF-1 in cancer therapy: two decade long story of a transcription factor.癌症治疗中的缺氧诱导因子-1:一个转录因子长达二十年的故事
Acta Oncol. 2017 Apr;56(4):503-515. doi: 10.1080/0284186X.2017.1301680.
5
Development of Inhibitors Targeting Hypoxia-Inducible Factor 1 and 2 for Cancer Therapy.靶向缺氧诱导因子1和2的抑制剂用于癌症治疗的研究进展
Yonsei Med J. 2017 May;58(3):489-496. doi: 10.3349/ymj.2017.58.3.489.
6
Mitochondrial composition and function under the control of hypoxia.缺氧调控下的线粒体组成与功能。
Redox Biol. 2017 Aug;12:208-215. doi: 10.1016/j.redox.2017.02.012. Epub 2017 Feb 24.
7
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer.缺氧和缺氧诱导因子在癌症中的治疗靶向。
Pharmacol Ther. 2016 Aug;164:152-69. doi: 10.1016/j.pharmthera.2016.04.009. Epub 2016 Apr 29.
8
Loss of SIRT3 Provides Growth Advantage for B Cell Malignancies.SIRT3缺失为B细胞恶性肿瘤提供生长优势。
J Biol Chem. 2016 Feb 12;291(7):3268-79. doi: 10.1074/jbc.M115.702076. Epub 2015 Dec 2.
9
Effect of hypoxia on tissue factor pathway inhibitor expression in breast cancer.缺氧对乳腺癌组织因子途径抑制物表达的影响。
J Thromb Haemost. 2016 Feb;14(2):387-96. doi: 10.1111/jth.13206. Epub 2016 Jan 30.
10
HIF-1α pathway: role, regulation and intervention for cancer therapy.缺氧诱导因子-1α通路:在癌症治疗中的作用、调控及干预
Acta Pharm Sin B. 2015 Sep;5(5):378-89. doi: 10.1016/j.apsb.2015.05.007. Epub 2015 Jun 6.